首页 > 最新文献

Immunobiology最新文献

英文 中文
Deferoxamine attenuates sepsis-induced liver injury by suppressing ferroptosis 去铁胺通过抑制铁下垂减轻败血症引起的肝损伤。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-03 DOI: 10.1016/j.imbio.2025.153125
Haidan Zhang, Hongyao Li, Shixian Liu, Jiahui Zheng, Peiwu Li

Background

The liver is among the organs most frequently damaged during sepsis, and sepsis-induced liver injury is an independent risk factor for early patient mortality. Ferroptosis has been implicated in sepsis-related organ dysfunction; however, its role in sepsis-induced liver injury remains unclear. This study aimed to investigate the role and underlying mechanisms of ferroptosis in sepsis-associated liver injury.

Methods

A rat sepsis model was established in vivo using cecal ligation and puncture (CLP). In vitro, BRL-3A hepatocytes were exposed to lipopolysaccharide (LPS). Deferoxamine (DFO) was administered prior to model induction. Inflammatory cytokine concentrations and the extent of liver injury were assessed. Ferroptosis-related biomarkers, including ferrous ions (Fe2+), prostaglandin-endoperoxide synthase 2 (PTGS2), acyl-CoA synthetase long-chain family member 4(ACSL4), malondialdehyde (MDA), glutathione (GSH) and peroxidase 4 (GPX4) were quantified. Lipid peroxidation was measured using the BODIPY 581/591 C11 fluorescent probe. Mitochondrial function was evaluated using electron microscopy and JC-1 fluorescent probe assays.

Results

(1) In vivo, DFO treatment was found to alleviate systemic inflammation in septic rats and provided protective effects on the liver. It increased the 7-day survival rate, reduced serum levels of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), decreased alanine aminotransferase and aspartate aminotransferase levels, and mitigated histopathological damage in liver tissue. In vitro, DFO treatment enhanced the viability of LPS-stimulated BRL-3A hepatocytes. (2) Ferroptosis was observed to be activated in septic rats as well as in LPS-stimulated BRL-3A hepatocytes. DFO reduced the intracellular concentration of ferrous ions and reduced lipid peroxidation as indicated by decreased PTGS2, ACSL4 and MDA. Furthermore, DFO alleviated mitochondrial damage (manifested as reduced mitochondrial volume, decreased membrane density, reduced cristae and outer membrane rupture, etc.), and mitochondrial function was improved. Finally, DFO elevated the levels of GSH and GPX4, which enhanced the antioxidant capacity of hepatocytes.

Conclusion

Ferroptosis plays a critical role in the pathogenesis of sepsis-induced liver injury. Targeting the activation of ferroptosis in hepatocytes during sepsis through intervention with DFO may represent a promising therapeutic strategy for the management of this condition.
背景:肝脏是败血症中最常受损的器官之一,败血症引起的肝损伤是早期患者死亡的独立危险因素。铁质下垂与败血症相关的器官功能障碍有关;然而,其在脓毒症引起的肝损伤中的作用尚不清楚。本研究旨在探讨铁下垂在脓毒症相关肝损伤中的作用和潜在机制。方法:采用盲肠结扎穿刺法(CLP)建立大鼠脓毒症模型。在体外,BRL-3A肝细胞暴露于脂多糖(LPS)。模型诱导前给予去铁胺(DFO)。评估炎症细胞因子浓度和肝损伤程度。测定了铁中毒相关的生物标志物,包括铁离子(Fe2+)、前列腺素内过氧化物合成酶2 (PTGS2)、酰基辅酶a合成酶长链家族成员4(ACSL4)、丙二醛(MDA)、谷胱甘肽(GSH)和过氧化物酶4(GPX4)。脂质过氧化用BODIPY 581/591 C11荧光探针检测。用电镜和JC-1荧光探针检测线粒体功能。结果:(1)在体内,DFO治疗可减轻脓毒症大鼠的全身炎症,并对肝脏有保护作用。提高大鼠7天生存率,降低血清白细胞介素-6 (IL-6)和肿瘤坏死因子-α (TNF-α)水平,降低丙氨酸转氨酶和天冬氨酸转氨酶水平,减轻肝组织病理损伤。在体外,DFO处理增强了lps刺激的BRL-3A肝细胞的活力。(2)在脓毒症大鼠和lps刺激的BRL-3A肝细胞中,观察到铁凋亡被激活。从PTGS2、ACSL4和MDA的降低可以看出,DFO降低了细胞内亚铁离子浓度,减少了脂质过氧化。DFO减轻了线粒体损伤(表现为线粒体体积减小、膜密度降低、嵴减少、外膜破裂等),改善了线粒体功能。最后,DFO提高了GSH和GPX4的水平,从而增强了肝细胞的抗氧化能力。结论:铁下垂在脓毒症肝损伤的发病机制中起重要作用。针对脓毒症期间肝细胞铁下垂的激活,通过DFO干预可能是一种很有前途的治疗策略。
{"title":"Deferoxamine attenuates sepsis-induced liver injury by suppressing ferroptosis","authors":"Haidan Zhang,&nbsp;Hongyao Li,&nbsp;Shixian Liu,&nbsp;Jiahui Zheng,&nbsp;Peiwu Li","doi":"10.1016/j.imbio.2025.153125","DOIUrl":"10.1016/j.imbio.2025.153125","url":null,"abstract":"<div><h3>Background</h3><div>The liver is among the organs most frequently damaged during sepsis, and sepsis-induced liver injury is an independent risk factor for early patient mortality. Ferroptosis has been implicated in sepsis-related organ dysfunction; however, its role in sepsis-induced liver injury remains unclear. This study aimed to investigate the role and underlying mechanisms of ferroptosis in sepsis-associated liver injury.</div></div><div><h3>Methods</h3><div>A rat sepsis model was established in vivo using cecal ligation and puncture (CLP). In vitro, BRL-3A hepatocytes were exposed to lipopolysaccharide (LPS). Deferoxamine (DFO) was administered prior to model induction. Inflammatory cytokine concentrations and the extent of liver injury were assessed. Ferroptosis-related biomarkers, including ferrous ions (Fe<sup>2+</sup>), prostaglandin-endoperoxide synthase 2 (PTGS2), acyl-CoA synthetase long-chain family member 4(ACSL4), malondialdehyde (MDA), glutathione (GSH) and peroxidase 4 (GPX4) were quantified. Lipid peroxidation was measured using the BODIPY 581/591 C11 fluorescent probe. Mitochondrial function was evaluated using electron microscopy and JC-1 fluorescent probe assays.</div></div><div><h3>Results</h3><div>(1) In vivo, DFO treatment was found to alleviate systemic inflammation in septic rats and provided protective effects on the liver. It increased the 7-day survival rate, reduced serum levels of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), decreased alanine aminotransferase and aspartate aminotransferase levels, and mitigated histopathological damage in liver tissue. In vitro, DFO treatment enhanced the viability of LPS-stimulated BRL-3A hepatocytes. (2) Ferroptosis was observed to be activated in septic rats as well as in LPS-stimulated BRL-3A hepatocytes. DFO reduced the intracellular concentration of ferrous ions and reduced lipid peroxidation as indicated by decreased PTGS2, ACSL4 and MDA. Furthermore, DFO alleviated mitochondrial damage (manifested as reduced mitochondrial volume, decreased membrane density, reduced cristae and outer membrane rupture, etc.), and mitochondrial function was improved. Finally, DFO elevated the levels of GSH and GPX4, which enhanced the antioxidant capacity of hepatocytes.</div></div><div><h3>Conclusion</h3><div>Ferroptosis plays a critical role in the pathogenesis of sepsis-induced liver injury. Targeting the activation of ferroptosis in hepatocytes during sepsis through intervention with DFO may represent a promising therapeutic strategy for the management of this condition.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153125"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of HLA-E polymorphism and soluble HLA-E isoform in recurrent reproductive failures and male infertility HLA-E多态性和可溶性HLA-E异构体在复发性生殖失败和男性不育中的作用
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-22 DOI: 10.1016/j.imbio.2025.153130
Agnieszka Tarnowska , Andrzej Wiśniewski , Julia Burnos , Paweł Radwan , Kazimierz Chorobik , Michał Radwan , Karolina Piekarska , Andrzej Malinowski , Jacek R. Wilczyński , Izabela Nowak

Background

Human leukocyte antigen (HLA)-E as a non-classical HLA class I molecule interacting with NK and T cell receptors may activate or inhibit immune responses. These reactions can impact reproductive success because HLA-E is expressed by trophoblast cells. In this study, we investigated rs1264457 A/G HLA-E polymorphism in couples with reproductive failures such as recurrent implantation failure (RIF) after in vitro fertilization (IVF), recurrent spontaneous abortion (RSA), and sporadic spontaneous abortion (SSA) after natural conception. Furthermore, we investigated the role of the soluble HLA-E isoform (sHLA-E) in women's plasma and seminal plasma of men participating in IVF procedures.

Methods

We used real-time PCR with a TaqMan probe to study the rs1264457 polymorphism, which represents a much better-known HLA-E*01:01/HLA-E*01:03 dimorphism, and ELISA test to measure the soluble HLA-E isoform.

Results

Our study indicates that the rs1264457 A/G polymorphism did not influence female infertility or susceptibility to RIF and RSA. However, we noticed that HLA-E*0101 homozygotic men were more susceptible to having severe, very severe oligozoospermia or azoospermia (p = 0.013, OR = 1.70). Moreover, we found a higher concentration of sHLA-E in IVF patients than in control women (p < 0.0001/pcorr. = 0.0024). In turn, a lower level of sHLA-E in semen plasma was associated with fewer sperm cells (p < 0.0001).

Conclusions

HLA-E*0101 homozygosity and lower levels of soluble HLA-E in men's ejaculate are associated with reduced sperm count and may impact male fertility.
人类白细胞抗原(HLA)-E作为一种非经典HLA I类分子与NK和T细胞受体相互作用,可激活或抑制免疫反应。这些反应可以影响生殖成功,因为HLA-E是由滋养细胞表达的。在本研究中,我们研究了rs1264457 A/G HLA-E多态性在体外受精(IVF)后复发性着床失败(RIF)、自然受孕后复发性自然流产(RSA)和散发性自然流产(SSA)等生殖失败夫妇中的多态性。此外,我们还研究了可溶性HLA-E异构体(sHLA-E)在参与体外受精程序的女性血浆和男性精浆中的作用。方法采用实时荧光定量PCR和TaqMan探针检测HLA-E*01:01/HLA-E*01:03双态rs1264457多态性,ELISA检测可溶性HLA-E异构体。结果rs1264457 A/G多态性不影响女性不育或对RIF和RSA的易感性。然而,我们注意到HLA-E*0101纯合子男性更容易发生严重、极严重的少精症或无精症(p = 0.013, or = 1.70)。此外,我们发现体外受精患者的sHLA-E浓度高于对照组(p < 0.0001/pcorr)。= 0.0024)。反过来,精液血浆中较低水平的sHLA-E与较少的精子细胞相关(p < 0.0001)。结论男性射精中shla - e *0101纯合性和可溶性HLA-E水平降低与精子数量减少有关,可能影响男性生育能力。
{"title":"The role of HLA-E polymorphism and soluble HLA-E isoform in recurrent reproductive failures and male infertility","authors":"Agnieszka Tarnowska ,&nbsp;Andrzej Wiśniewski ,&nbsp;Julia Burnos ,&nbsp;Paweł Radwan ,&nbsp;Kazimierz Chorobik ,&nbsp;Michał Radwan ,&nbsp;Karolina Piekarska ,&nbsp;Andrzej Malinowski ,&nbsp;Jacek R. Wilczyński ,&nbsp;Izabela Nowak","doi":"10.1016/j.imbio.2025.153130","DOIUrl":"10.1016/j.imbio.2025.153130","url":null,"abstract":"<div><h3>Background</h3><div>Human leukocyte antigen (HLA)-E as a non-classical HLA class I molecule interacting with NK and T cell receptors may activate or inhibit immune responses. These reactions can impact reproductive success because HLA-E is expressed by trophoblast cells. In this study, we investigated rs1264457 A/G HLA-E polymorphism in couples with reproductive failures such as recurrent implantation failure (RIF) after in vitro fertilization (IVF), recurrent spontaneous abortion (RSA), and sporadic spontaneous abortion (SSA) after natural conception. Furthermore, we investigated the role of the soluble HLA-E isoform (sHLA-E) in women's plasma and seminal plasma of men participating in IVF procedures.</div></div><div><h3>Methods</h3><div>We used real-time PCR with a TaqMan probe to study the rs1264457 polymorphism, which represents a much better-known <em>HLA-E*01:01/HLA-E*01:03</em> dimorphism, and ELISA test to measure the soluble HLA-E isoform.</div></div><div><h3>Results</h3><div>Our study indicates that the rs1264457 A/G polymorphism did not influence female infertility or susceptibility to RIF and RSA. However, we noticed that <em>HLA-E*0101</em> homozygotic men were more susceptible to having severe, very severe oligozoospermia or azoospermia (<em>p</em> = 0.013, OR = 1.70). Moreover, we found a higher concentration of sHLA-E in IVF patients than in control women (<em>p</em> &lt; 0.0001/p<sub>corr.</sub> = 0.0024). In turn, a lower level of sHLA-E in semen plasma was associated with fewer sperm cells (p &lt; 0.0001).</div></div><div><h3>Conclusions</h3><div><em>HLA-E*0101</em> homozygosity and lower levels of soluble HLA-E in men's ejaculate are associated with reduced sperm count and may impact male fertility.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153130"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145358094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-phase study of CD4+CXCR4+ T cells in Mycoplasma pneumoniae pneumonia: clinical correlations in children and therapeutic exploration with tofacitinib in mice CD4+CXCR4+ T细胞在肺炎支原体肺炎中的双期研究:儿童的临床相关性及托法替尼在小鼠中的治疗探索
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.imbio.2025.153136
Kaiwen Wang , Li Guo , Yongqi Zhang , Haiting Yang , Zhenghan Zhao , Hui Du , Jiangfeng Zhao
<div><h3>Objective</h3><div>This study had two primary objectives. First, we aimed to investigate whether differential expression of the chemokine receptor CXCR4 on CD4<sup>+</sup> T lymphocytes could serve as a distinguishing immunological feature between pediatric patients with severe <em>Mycoplasma pneumoniae</em> pneumonia (SMPP) and those with on- Non-severe MPP. Second, we sought to explore the therapeutic potential of the JAK inhibitor Tofacitinib in MPP by examining its effects on CXCR4 pathway modulation, using both clinical observations and experimental validation through an established animal model of MPP.</div></div><div><h3>Methods</h3><div>We conducted a prospective cohort study involving 267 pediatric patients diagnosed with MPP at Jiading District Central Hospital between 2023 and 2024, comprising 42 SMPP cases and 225 Non-severe MPP cases. Baseline clinical and laboratory parameters were systematically collected within 24 h of hospital admission. Flow cytometry was employed to quantify the percentage of CD4<sup>+</sup> T cells expressing CXCR4 (CD4<sup>+</sup>CXCR4<sup>+</sup>) in peripheral blood samples by flow cytometry. For mechanistic investigation, we established a murine model of MPP to evaluate the immunomodulatory effects of Tofacitinib. Treatment groups received either vehicle control or Tofacitinib, after which we analyzed bronchoalveolar lavage fluid (BALF) for inflammatory cytokines (IL-6, IL-8, IP-10, IL-2) and CXCL12 levels via ELISA. Additionally, in vitro experiments were performed using the murine lung epithelial cell line MLE-12 to assess the combined effects of Tofacitinib and a CXCR4 inhibitor on key inflammatory signaling pathways (JAK-STAT and NF-κB) through Western blot analysis.</div></div><div><h3>Results</h3><div>Clinical analysis revealed that children with SMPP had significantly prolonged fever duration (<em>P</em> = 0.0062), extended hospitalization (<em>P</em> < 0.0001), elevated erythrocyte sedimentation rate (<em>P</em> = 0.0161), and higher proportions of CD4<sup>+</sup>CXCR4<sup>+</sup> T lymphocytes (<em>P</em> < 0.0001) compared to Non-severe MPP patients. However, no statistically significant differences were observed in serum levels of C-reactive protein, procalcitonin, or lactate dehydrogenase between the two groups. In the MPP mouse model, BALF analysis demonstrated marked increases in pro-inflammatory cytokines (IL-6, IL-8, IP-10, IL-2) and CXCL12 (<em>P</em> < 0.05), all of which were significantly attenuated by Tofacitinib treatment. Furthermore, Tofacitinib administration reduced CXCR4 expression on CD4<sup>+</sup> T cells in lung tissues. In vitro experiments confirmed that the combination of Tofacitinib and a CXCR4 inhibitor synergistically suppressed activation of the JAK-STAT and NF-κB pathways.</div></div><div><h3>Conclusion</h3><div>Our findings indicate that elevated CD4<sup>+</sup>CXCR4<sup>+</sup> T cell proportions may serve as a predictive biomarker for disease seve
目的:本研究有两个主要目的。首先,我们的目的是研究趋化因子受体CXCR4在CD4+ T淋巴细胞上的差异表达是否可以作为儿童重症肺炎支原体肺炎(SMPP)患者与非重症肺炎支原体肺炎患者之间的区别免疫特征。其次,我们通过建立MPP动物模型,通过临床观察和实验验证,研究JAK抑制剂Tofacitinib对CXCR4通路调节的影响,探索其在MPP中的治疗潜力。方法:我们开展了一项前瞻性队列研究,纳入了2023年至2024年在嘉定区中心医院诊断为MPP的267例儿科患者,其中42例为SMPP, 225例为非重度MPP。入院24小时内系统收集基线临床和实验室参数。采用流式细胞术定量外周血样本中表达CXCR4的CD4+ T细胞(CD4+CXCR4+)的百分比。为了进行机制研究,我们建立了小鼠MPP模型,以评价托法替尼的免疫调节作用。治疗组分别给予对照或托法替尼,之后通过ELISA分析支气管肺泡灌洗液(BALF)中炎症因子(IL-6、IL-8、IP-10、IL-2)和CXCL12水平。此外,利用小鼠肺上皮细胞系MLE-12进行体外实验,通过Western blot分析Tofacitinib和CXCR4抑制剂联合使用对关键炎症信号通路(JAK-STAT和NF-κB)的影响。结果:临床分析显示,SMPP患儿发热时间明显延长(P = 0.0062),住院时间明显延长(P +CXCR4+ T淋巴细胞)。体外实验证实,Tofacitinib与CXCR4抑制剂联合使用可协同抑制JAK-STAT和NF-κB通路的激活。结论:我们的研究结果表明,CD4+CXCR4+ T细胞比例升高可能是儿童MPP疾病严重程度的预测性生物标志物。实验数据表明,Tofacitinib通过调节CXCL12/CXCR4轴对MPP产生保护作用,导致炎症细胞因子的产生减少。观察到的JAK-STAT和NF-κB信号通路的抑制为Tofacitinib在MPP治疗中的潜在治疗应用提供了机制支持,无论是单独使用还是与CXCR4抑制剂联合使用。需要进一步的临床研究来验证这些发现,并评估这种治疗策略的转化潜力。
{"title":"Dual-phase study of CD4+CXCR4+ T cells in Mycoplasma pneumoniae pneumonia: clinical correlations in children and therapeutic exploration with tofacitinib in mice","authors":"Kaiwen Wang ,&nbsp;Li Guo ,&nbsp;Yongqi Zhang ,&nbsp;Haiting Yang ,&nbsp;Zhenghan Zhao ,&nbsp;Hui Du ,&nbsp;Jiangfeng Zhao","doi":"10.1016/j.imbio.2025.153136","DOIUrl":"10.1016/j.imbio.2025.153136","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;This study had two primary objectives. First, we aimed to investigate whether differential expression of the chemokine receptor CXCR4 on CD4&lt;sup&gt;+&lt;/sup&gt; T lymphocytes could serve as a distinguishing immunological feature between pediatric patients with severe &lt;em&gt;Mycoplasma pneumoniae&lt;/em&gt; pneumonia (SMPP) and those with on- Non-severe MPP. Second, we sought to explore the therapeutic potential of the JAK inhibitor Tofacitinib in MPP by examining its effects on CXCR4 pathway modulation, using both clinical observations and experimental validation through an established animal model of MPP.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We conducted a prospective cohort study involving 267 pediatric patients diagnosed with MPP at Jiading District Central Hospital between 2023 and 2024, comprising 42 SMPP cases and 225 Non-severe MPP cases. Baseline clinical and laboratory parameters were systematically collected within 24 h of hospital admission. Flow cytometry was employed to quantify the percentage of CD4&lt;sup&gt;+&lt;/sup&gt; T cells expressing CXCR4 (CD4&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt;) in peripheral blood samples by flow cytometry. For mechanistic investigation, we established a murine model of MPP to evaluate the immunomodulatory effects of Tofacitinib. Treatment groups received either vehicle control or Tofacitinib, after which we analyzed bronchoalveolar lavage fluid (BALF) for inflammatory cytokines (IL-6, IL-8, IP-10, IL-2) and CXCL12 levels via ELISA. Additionally, in vitro experiments were performed using the murine lung epithelial cell line MLE-12 to assess the combined effects of Tofacitinib and a CXCR4 inhibitor on key inflammatory signaling pathways (JAK-STAT and NF-κB) through Western blot analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Clinical analysis revealed that children with SMPP had significantly prolonged fever duration (&lt;em&gt;P&lt;/em&gt; = 0.0062), extended hospitalization (&lt;em&gt;P&lt;/em&gt; &lt; 0.0001), elevated erythrocyte sedimentation rate (&lt;em&gt;P&lt;/em&gt; = 0.0161), and higher proportions of CD4&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; T lymphocytes (&lt;em&gt;P&lt;/em&gt; &lt; 0.0001) compared to Non-severe MPP patients. However, no statistically significant differences were observed in serum levels of C-reactive protein, procalcitonin, or lactate dehydrogenase between the two groups. In the MPP mouse model, BALF analysis demonstrated marked increases in pro-inflammatory cytokines (IL-6, IL-8, IP-10, IL-2) and CXCL12 (&lt;em&gt;P&lt;/em&gt; &lt; 0.05), all of which were significantly attenuated by Tofacitinib treatment. Furthermore, Tofacitinib administration reduced CXCR4 expression on CD4&lt;sup&gt;+&lt;/sup&gt; T cells in lung tissues. In vitro experiments confirmed that the combination of Tofacitinib and a CXCR4 inhibitor synergistically suppressed activation of the JAK-STAT and NF-κB pathways.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Our findings indicate that elevated CD4&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; T cell proportions may serve as a predictive biomarker for disease seve","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153136"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complement at the crossroads of inflammation and metabolism: implications for diabetes and metabolic functions 炎症和代谢十字路口的补体:对糖尿病和代谢功能的影响。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-09-05 DOI: 10.1016/j.imbio.2025.153113
Vaishnavi Dandavate, Anna M. Blom, Ben C. King
Diabetes is a growing global problem, with hundreds of millions of people living with the disease worldwide. Diabetes can be divided into two major subtypes, autoimmune type 1 diabetes (T1D), and type 2 diabetes (T2D), which has stronger causal links in obesity, lifestyle, and age. Although immunity and inflammation are clearly defined in T1D, it is also understood that inflammation has a role in metabolic dysregulation in T2D, inducing insulin resistance as well as affecting β-cell function, survival, and therefore insulin secretion. Cytokines and other inflammatory mediators can affect function of cells important for metabolism, most studied in adipose tissue, muscle, and pancreatic islets. Similarly, evidence shows that complement can also have positive roles in metabolic homeostasis in adipose tissue and pancreatic islets. This review will give an introduction to this field, with focus on established and emerging roles of the complement system, an arm of humoral innate immunity that has been found to have roles in metabolic homeostasis.
糖尿病是一个日益严重的全球性问题,全世界有数亿人患有这种疾病。糖尿病可分为两大亚型,自身免疫性1型糖尿病(T1D)和2型糖尿病(T2D),其与肥胖、生活方式和年龄有更强的因果关系。虽然免疫和炎症在T1D中有明确的定义,但我们也知道炎症在T2D的代谢失调中起作用,诱导胰岛素抵抗,影响β细胞功能、存活,从而影响胰岛素分泌。细胞因子和其他炎症介质可影响代谢重要细胞的功能,在脂肪组织、肌肉和胰岛中研究最多。同样,有证据表明补体也可以在脂肪组织和胰岛的代谢稳态中发挥积极作用。本文将介绍这一领域,重点介绍补体系统已建立的和新出现的作用,补体系统是体液先天免疫的一个分支,已被发现在代谢稳态中起作用。
{"title":"Complement at the crossroads of inflammation and metabolism: implications for diabetes and metabolic functions","authors":"Vaishnavi Dandavate,&nbsp;Anna M. Blom,&nbsp;Ben C. King","doi":"10.1016/j.imbio.2025.153113","DOIUrl":"10.1016/j.imbio.2025.153113","url":null,"abstract":"<div><div>Diabetes is a growing global problem, with hundreds of millions of people living with the disease worldwide. Diabetes can be divided into two major subtypes, autoimmune type 1 diabetes (T1D), and type 2 diabetes (T2D), which has stronger causal links in obesity, lifestyle, and age. Although immunity and inflammation are clearly defined in T1D, it is also understood that inflammation has a role in metabolic dysregulation in T2D, inducing insulin resistance as well as affecting β-cell function, survival, and therefore insulin secretion. Cytokines and other inflammatory mediators can affect function of cells important for metabolism, most studied in adipose tissue, muscle, and pancreatic islets. Similarly, evidence shows that complement can also have positive roles in metabolic homeostasis in adipose tissue and pancreatic islets. This review will give an introduction to this field, with focus on established and emerging roles of the complement system, an arm of humoral innate immunity that has been found to have roles in metabolic homeostasis.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153113"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145085992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system 脊髓灰质炎疫苗神经毒力检测的新方法:增强型4级评分系统的发展。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-09-29 DOI: 10.1016/j.imbio.2025.153121
Xi Wang , Yunguang Hu , Anguo Yin , Changxu Chen , Hong Xiang , Li Wang , Bochuan Liu , Yuan Tian , Yu Gao , Mingrun Zhang , Yan Li , Yina Cun , Jian Zhou
The ongoing promotion and administration of vaccines play a critical role in the global effort to eradicate poliovirus. The Monkey Neurovirulence Test (MNVT) is an essential method for evaluating the neurovirulence of viruses in both the Oral Attenuated Live Poliovirus Vaccine (OPV) and the Sabin Inactivated Poliovirus Vaccine (sIPV) to ensure they meet required safety standards. The “4-level scoring method” recommended by the World Health Organization (WHO) has served as a key pathological evaluation criterion in this test. However, its lack of scoring granularity often leads to subjective interpretation discrepancies among evaluators, which compromises the consistency and reliability of the MNVT results. To address these limitations, we have mapped the primary neuronal nuclei in monkey tissue sections and analyzed viral-induced damage distribution. As a result, we developed an Enhanced 4-Level Scoring System (integrating precise anatomical mapping and quantitative lesion analysis), which minimizes evaluator bias and significantly improves scoring stability and consistency.
正在进行的疫苗推广和接种工作在全球根除脊髓灰质炎病毒的努力中发挥着关键作用。猴神经毒力试验(MNVT)是评估口服脊髓灰质炎减毒活疫苗(OPV)和沙宾灭活脊髓灰质炎疫苗(sIPV)中病毒神经毒力的重要方法,以确保它们符合规定的安全标准。世界卫生组织(WHO)推荐的“4级评分法”作为本试验的主要病理评价标准。然而,它缺乏评分粒度,常常导致评估者之间的主观解释差异,从而损害了MNVT结果的一致性和可靠性。为了解决这些局限性,我们绘制了猴组织切片的初级神经元核,并分析了病毒诱导的损伤分布。因此,我们开发了一个增强的4级评分系统(整合精确的解剖制图和定量的病变分析),它最大限度地减少了评估者的偏见,并显著提高了评分的稳定性和一致性。
{"title":"A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system","authors":"Xi Wang ,&nbsp;Yunguang Hu ,&nbsp;Anguo Yin ,&nbsp;Changxu Chen ,&nbsp;Hong Xiang ,&nbsp;Li Wang ,&nbsp;Bochuan Liu ,&nbsp;Yuan Tian ,&nbsp;Yu Gao ,&nbsp;Mingrun Zhang ,&nbsp;Yan Li ,&nbsp;Yina Cun ,&nbsp;Jian Zhou","doi":"10.1016/j.imbio.2025.153121","DOIUrl":"10.1016/j.imbio.2025.153121","url":null,"abstract":"<div><div>The ongoing promotion and administration of vaccines play a critical role in the global effort to eradicate poliovirus. The Monkey Neurovirulence Test (MNVT) is an essential method for evaluating the neurovirulence of viruses in both the Oral Attenuated Live Poliovirus Vaccine (OPV) and the Sabin Inactivated Poliovirus Vaccine (sIPV) to ensure they meet required safety standards. The “4-level scoring method” recommended by the World Health Organization (WHO) has served as a key pathological evaluation criterion in this test. However, its lack of scoring granularity often leads to subjective interpretation discrepancies among evaluators, which compromises the consistency and reliability of the MNVT results. To address these limitations, we have mapped the primary neuronal nuclei in monkey tissue sections and analyzed viral-induced damage distribution. As a result, we developed an Enhanced 4-Level Scoring System (integrating precise anatomical mapping and quantitative lesion analysis), which minimizes evaluator bias and significantly improves scoring stability and consistency.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153121"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Programmed cell death ligand 1 mediates antigen presentation, apoptosis, necrosis, and inflammatory response in Klebsiella pneumoniae-infected macrophages 程序性细胞死亡配体1介导肺炎克雷伯菌感染巨噬细胞的抗原呈递、凋亡、坏死和炎症反应
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-26 DOI: 10.1016/j.imbio.2025.153133
Xiaoya Zheng , Weihong Tang , Qiaoqiao Tang , Qiao Wu , Jiancong Shan
Klebsiella pneumoniae (Kp) infection has high global complication and mortality rate. Programmed cell death ligand 1 (PD-L1) is important for immune evasion in tumorigenesis, however, with unclear mechanism in Kp infection. This study aims to explore the role and potential mechanisms of PD-L1 in Kp-infected mouse mononuclear macrophages RAW264.7 cells. Here, RAW264.7 cells were infected with classical Kp (cKp) and highly virulent Kp (hvKp), and transfected with PD-L1 knockdown. Subsequently, to investigate the effect of PD-L1 on the activation of CD4+ T cells, a co-culture system of RAW264.7 and CD4+ T cells was established. In RAW264.7 cells infected with Kp, PD-L1 knockdown reduced apoptosis and necrosis, with lower Bax, Cleaved Caspase 3, p-RIPK1/RIPK1, p-RIPK3/RIPK3, and p-MLKL/MLKL expression. Meanwhile, phagocytic activity and phagocytic index were enhanced, with increased Kp count. Furthermore, PD-L1 knockdown led to the activation of RAW264.7 cells, which participated in immune regulation, accompanied by higher levels of IL-1β, IL-6, TNF-α, MHC II, CD80, and CD86. Following co-culture of RAW264.7 and CD4+ T cells, PD-L1 knockdown reversed the effect of Kp infection to promote CD4+ T cell activation, as evidenced by decreased apoptosis and elevated IFN-γ, TNF-α, and IL-2 levels. This result preliminarily demonstrated that PD-L1 expression may be involved in antigen presentation in RAW264.7 cells with Kp infection. In conclusion, in Kp-infected RAW264.7 cells, PD-L1 mediates the increased apoptosis, necrosis, inflammatory responses, and CD4+ T cell activation, as well as inhibition of phagocytosis, and may be involved in antigen presentation, offering new therapeutic targets for Kp infection.
肺炎克雷伯菌(Kp)感染具有很高的全球并发症和死亡率。程序性细胞死亡配体1 (PD-L1)在肿瘤发生的免疫逃避中起重要作用,但在Kp感染中的机制尚不清楚。本研究旨在探讨PD-L1在kp感染小鼠单核巨噬细胞RAW264.7细胞中的作用及其潜在机制。在这里,RAW264.7细胞被经典Kp (cKp)和高毒力Kp (hvKp)感染,并转染PD-L1敲低。随后,为了研究PD-L1对CD4+ T细胞活化的影响,我们建立了RAW264.7与CD4+ T细胞共培养体系。在感染Kp的RAW264.7细胞中,PD-L1敲低可减少细胞凋亡和坏死,降低Bax、Cleaved Caspase 3、p-RIPK1/RIPK1、p-RIPK3/RIPK3和p-MLKL/MLKL的表达。同时,随着Kp计数的增加,吞噬活性和吞噬指数增强。此外,PD-L1敲低导致RAW264.7细胞活化,参与免疫调节,并伴有IL-1β、IL-6、TNF-α、MHC II、CD80和CD86水平升高。RAW264.7和CD4+ T细胞共培养后,PD-L1敲低逆转了Kp感染促进CD4+ T细胞活化的作用,凋亡减少,IFN-γ、TNF-α和IL-2水平升高。这一结果初步证明,PD-L1的表达可能参与了Kp感染RAW264.7细胞的抗原呈递。综上所述,在Kp感染的RAW264.7细胞中,PD-L1介导凋亡、坏死、炎症反应、CD4+ T细胞活化和吞噬抑制的增加,并可能参与抗原递呈,为Kp感染提供了新的治疗靶点。
{"title":"Programmed cell death ligand 1 mediates antigen presentation, apoptosis, necrosis, and inflammatory response in Klebsiella pneumoniae-infected macrophages","authors":"Xiaoya Zheng ,&nbsp;Weihong Tang ,&nbsp;Qiaoqiao Tang ,&nbsp;Qiao Wu ,&nbsp;Jiancong Shan","doi":"10.1016/j.imbio.2025.153133","DOIUrl":"10.1016/j.imbio.2025.153133","url":null,"abstract":"<div><div><em>Klebsiella pneumoniae</em> (Kp) infection has high global complication and mortality rate. Programmed cell death ligand 1 (PD-L1) is important for immune evasion in tumorigenesis, however, with unclear mechanism in Kp infection. This study aims to explore the role and potential mechanisms of PD-L1 in Kp-infected mouse mononuclear macrophages RAW264.7 cells. Here, RAW264.7 cells were infected with classical Kp (cKp) and highly virulent Kp (hvKp), and transfected with PD-L1 knockdown. Subsequently, to investigate the effect of PD-L1 on the activation of CD4<sup>+</sup> T cells, a co-culture system of RAW264.7 and CD4<sup>+</sup> T cells was established. In RAW264.7 cells infected with Kp, PD-L1 knockdown reduced apoptosis and necrosis, with lower Bax, Cleaved Caspase 3, p-RIPK1/RIPK1, p-RIPK3/RIPK3, and p-MLKL/MLKL expression. Meanwhile, phagocytic activity and phagocytic index were enhanced, with increased Kp count. Furthermore, PD-L1 knockdown led to the activation of RAW264.7 cells, which participated in immune regulation, accompanied by higher levels of IL-1β, IL-6, TNF-α, MHC II, CD80, and CD86. Following co-culture of RAW264.7 and CD4<sup>+</sup> T cells, PD-L1 knockdown reversed the effect of Kp infection to promote CD4<sup>+</sup> T cell activation, as evidenced by decreased apoptosis and elevated IFN-γ, TNF-α, and IL-2 levels. This result preliminarily demonstrated that PD-L1 expression may be involved in antigen presentation in RAW264.7 cells with Kp infection. In conclusion, in Kp-infected RAW264.7 cells, PD-L1 mediates the increased apoptosis, necrosis, inflammatory responses, and CD4<sup>+</sup> T cell activation, as well as inhibition of phagocytosis, and may be involved in antigen presentation, offering new therapeutic targets for Kp infection.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153133"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145416596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The grand escape – how pathogens outsmart the human complement system 大逃亡——病原体如何智胜人体补体系统。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-24 DOI: 10.1016/j.imbio.2025.153126
A.A. Nowacka , L. Sordo Vieira , V. Petr , B. Fageräng , R. Würzner , M. Ohms
Infectious diseases remain a significant cause of mortality and morbidity worldwide. Complement is a critical component in the defense against pathogens and despite their great differences, viruses, bacteria, fungi, and protists have all developed similar mechanisms of evasion from the human complement system. Using examples from four microbial groups (viruses, bacteria, fungi and protists), this review expands on examples of these different mechanisms of evasion. The mechanisms are grouped as (A) avoidance of recognition, (B) avoidance of eradication, (C) avoidance of activation and function, or (D) use of the complement proteins for entry into the host, in accordance with the classification initially proposed in 1999. Furthermore, this review will expand on novel descriptions of complement evasion, for example involving intracellular complement. Taken toge complement evasion is an essential tool used by pathogens not only in a defensive manner, protecting the pathogen from the host, but can also employed in an aggressive manner to aid the invasion of the host. Understanding these mechanisms has already influenced diagnostic and therapeutic tools, including vaccine development, and a further expansion of evasion molecules as biomarkers, vaccines or targets for therapy appears likely in the future.
传染病仍然是全世界死亡和发病的一个重要原因。补体是防御病原体的关键组成部分,尽管它们之间存在很大差异,但病毒、细菌、真菌和原生生物都发展出类似的逃避人体补体系统的机制。本文以四种微生物类群(病毒、细菌、真菌和原生生物)为例,详细介绍了这些不同的逃避机制。根据1999年最初提出的分类,这些机制被分为(A)避免识别,(B)避免根除,(C)避免激活和功能,或(D)利用补体蛋白进入宿主。此外,本综述将扩展对补体逃避的新描述,例如涉及细胞内补体。总的来说,补体逃避是病原体使用的重要工具,不仅以防御的方式保护病原体免受宿主的侵害,而且还可以以积极的方式帮助入侵宿主。了解这些机制已经影响了包括疫苗开发在内的诊断和治疗工具,并且在未来可能会进一步扩大逃避分子作为生物标志物、疫苗或治疗靶点的范围。
{"title":"The grand escape – how pathogens outsmart the human complement system","authors":"A.A. Nowacka ,&nbsp;L. Sordo Vieira ,&nbsp;V. Petr ,&nbsp;B. Fageräng ,&nbsp;R. Würzner ,&nbsp;M. Ohms","doi":"10.1016/j.imbio.2025.153126","DOIUrl":"10.1016/j.imbio.2025.153126","url":null,"abstract":"<div><div>Infectious diseases remain a significant cause of mortality and morbidity worldwide. Complement is a critical component in the defense against pathogens and despite their great differences, viruses, bacteria, fungi, and protists have all developed similar mechanisms of evasion from the human complement system. Using examples from four microbial groups (viruses, bacteria, fungi and protists), this review expands on examples of these different mechanisms of evasion. The mechanisms are grouped as (A) avoidance of recognition, (B) avoidance of eradication, (C) avoidance of activation and function, or (D) use of the complement proteins for entry into the host, in accordance with the classification initially proposed in 1999. Furthermore, this review will expand on novel descriptions of complement evasion, for example involving intracellular complement. Taken toge complement evasion is an essential tool used by pathogens not only in a defensive manner, protecting the pathogen from the host, but can also employed in an aggressive manner to aid the invasion of the host. Understanding these mechanisms has already influenced diagnostic and therapeutic tools, including vaccine development, and a further expansion of evasion molecules as biomarkers, vaccines or targets for therapy appears likely in the future.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153126"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impacts of Acute High-Level Gamma Radiation Exposure on immunological parameters in the blood of rats 急性高水平伽玛辐射暴露对大鼠血液免疫参数的影响。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-25 DOI: 10.1016/j.imbio.2025.153131
Soha M. Hussien
Gamma radiation (γR) influences cytokine regulation, with high doses (HD) producing marked biological effects under both controlled and accidental exposure scenarios. This study investigates the immunological responses to γR at doses of 2, 3, and 5 Gray (Gy) by examining T-cell receptor (TCR) mRNA expression, serum levels of Interleukin-10 (IL-10), Transforming Growth Factor-β (TGF-β), and Nitric Oxide (NO), as well as hematological parameters. These effects were compared between days 1 and 4 post-irradiation. Forty-eight male rats were randomly allocated into eight groups (six rats each), with Groups I and V serving as non-irradiated controls. Groups II–IV and Groups VI–VIII received whole-body γ-irradiation at doses of 2, 3, and 5 Gy, respectively. On days 1 and 4 after exposure, reverse transcription quantitative PCR (RT-qPCR) and standard hematological techniques were employed to assess gene expression, cytokine levels, hemoglobin concentration, hematocrit percentage, blood cell counts, and organ weights. This study demonstrates that high-dose γ-radiation (2–5 Gy) significantly (P < 0.05) increases TCR mRNA expression, hematological indices, and lymphoid organ weights, while IL-10 declines (P < 0.05), and TGF-β and nitric oxide levels are markedly elevated. Despite these observations, the null hypothesis was accepted for both time points (P > 0.05), indicating that there were no statistically significant differences across specific parameters. The observed inverse correlation between radiation exposure and lymphoid organ development supports the role of γR in altering immune-regulatory cytokines. Ultimately, higher γR doses tend to produce more pronounced immunological alterations, regardless of the intent of exposure.
γ辐射(γR)影响细胞因子调节,高剂量(HD)在受控和意外照射情景下均产生显著的生物效应。本研究通过检测t细胞受体(TCR) mRNA表达、血清白细胞介素-10 (IL-10)、转化生长因子-β (TGF-β)和一氧化氮(NO)水平以及血液学参数,探讨γ - r对2、3和5 Gray (Gy)剂量的免疫反应。这些效应在照射后第1天和第4天进行比较。48只雄性大鼠被随机分为8组(每组6只),第一组和第五组作为未受辐射的对照组。II-IV组和VI-VIII组分别接受2、3和5 Gy剂量的全身γ辐射。暴露后第1天和第4天,采用反转录定量PCR (RT-qPCR)和标准血液学技术评估基因表达、细胞因子水平、血红蛋白浓度、红细胞比容百分比、血细胞计数和器官重量。本研究表明,高剂量γ-辐射(2-5 Gy)显著(P 0.05),说明各具体参数间差异无统计学意义。观察到的辐射暴露与淋巴器官发育之间的负相关支持γR在改变免疫调节细胞因子中的作用。最终,无论暴露的目的如何,较高的γ - r剂量往往会产生更明显的免疫改变。
{"title":"The Impacts of Acute High-Level Gamma Radiation Exposure on immunological parameters in the blood of rats","authors":"Soha M. Hussien","doi":"10.1016/j.imbio.2025.153131","DOIUrl":"10.1016/j.imbio.2025.153131","url":null,"abstract":"<div><div>Gamma radiation (γR) influences cytokine regulation, with high doses (HD) producing marked biological effects under both controlled and accidental exposure scenarios. This study investigates the immunological responses to γR at doses of 2, 3, and 5 Gray (Gy) by examining T-cell receptor (TCR) mRNA expression, serum levels of Interleukin-10 (IL-10), Transforming Growth Factor-β (TGF-β), and Nitric Oxide (NO), as well as hematological parameters. These effects were compared between days 1 and 4 post-irradiation. Forty-eight male rats were randomly allocated into eight groups (six rats each), with Groups I and V serving as non-irradiated controls. Groups II–IV and Groups VI–VIII received whole-body γ-irradiation at doses of 2, 3, and 5 Gy, respectively. On days 1 and 4 after exposure, reverse transcription quantitative PCR (RT-qPCR) and standard hematological techniques were employed to assess gene expression, cytokine levels, hemoglobin concentration, hematocrit percentage, blood cell counts, and organ weights. This study demonstrates that high-dose γ-radiation (2–5 Gy) significantly (<em>P</em> &lt; 0.05) increases TCR mRNA expression, hematological indices, and lymphoid organ weights, while IL-10 declines (P &lt; 0.05), and TGF-β and nitric oxide levels are markedly elevated. Despite these observations, the null hypothesis was accepted for both time points (<em>P</em> &gt; 0.05), indicating that there were no statistically significant differences across specific parameters. The observed inverse correlation between radiation exposure and lymphoid organ development supports the role of γR in altering immune-regulatory cytokines. Ultimately, higher γR doses tend to produce more pronounced immunological alterations, regardless of the intent of exposure.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153131"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145389066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NLRX1 as a novel therapeutic target: TRAF6-dependent inhibition of acute rejection in rat liver transplantation NLRX1作为新的治疗靶点:traf6依赖性抑制大鼠肝移植急性排斥反应。
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-11-07 DOI: 10.1016/j.imbio.2025.153141
Zilun Lei , Tong Mou , Hao Chai , Qiang Liu , Ziqi Zhang
Recent research has underscored NLRX1's role in modulating hepatic immune responses. However, its function in Kupffer cells (KCs) during acute rejection (AR) post-liver transplantation is not well elucidated, and the mechanisms driving hepatic AR require deeper investigation. Our study found that NLRX1 expression was markedly reduced in hepatic AR models, both in vivo and in vitro. NLRX1 overexpression significantly dampened the activation of the MAPK and IKK pathways, leading to decreased cytokine secretion and mitigated liver damage and apoptosis. In contrast, NLRX1 downregulation intensified these adverse effects. Further mechanistic studies indicated that NLRX1's interaction with TRAF6 was crucial for its anti-inflammatory effects, which could be nullified by TRAF6 blockade. Moreover, in vitro assays showed that NLRX1 could drive KCs to transition from a pro-inflammatory M1 to an anti-inflammatory M2 phenotype via the PI3K/Akt pathway. Overall, our results imply that targeting NLRX1 in conjunction with mTOR could be a viable approach to prevent hepatic AR, and suggest potential cross-talk between TRAF6-dependent inflammatory suppression and PI3K/Akt-mediated M2 polarization that requires further validation.
最近的研究强调了NLRX1在调节肝脏免疫反应中的作用。然而,其在库普弗细胞(KCs)中在肝移植后急性排斥反应(AR)中的功能尚不清楚,其驱动肝AR的机制有待深入研究。我们的研究发现,在体内和体外的肝脏AR模型中,NLRX1的表达均显著降低。NLRX1过表达显著抑制MAPK和IKK通路的激活,导致细胞因子分泌减少,减轻肝损伤和凋亡。相反,NLRX1下调加剧了这些不良反应。进一步的机制研究表明,NLRX1与TRAF6的相互作用对其抗炎作用至关重要,可被TRAF6阻断。此外,体外实验表明NLRX1可以通过PI3K/Akt途径驱动KCs从促炎M1表型转变为抗炎M2表型。总的来说,我们的研究结果表明,靶向NLRX1与mTOR联合可能是预防肝脏AR的可行方法,并提示traf6依赖性炎症抑制与PI3K/ akt介导的M2极化之间可能存在串扰,这需要进一步验证。
{"title":"NLRX1 as a novel therapeutic target: TRAF6-dependent inhibition of acute rejection in rat liver transplantation","authors":"Zilun Lei ,&nbsp;Tong Mou ,&nbsp;Hao Chai ,&nbsp;Qiang Liu ,&nbsp;Ziqi Zhang","doi":"10.1016/j.imbio.2025.153141","DOIUrl":"10.1016/j.imbio.2025.153141","url":null,"abstract":"<div><div>Recent research has underscored NLRX1's role in modulating hepatic immune responses. However, its function in Kupffer cells (KCs) during acute rejection (AR) post-liver transplantation is not well elucidated, and the mechanisms driving hepatic AR require deeper investigation. Our study found that NLRX1 expression was markedly reduced in hepatic AR models, both in vivo and in vitro. NLRX1 overexpression significantly dampened the activation of the MAPK and IKK pathways, leading to decreased cytokine secretion and mitigated liver damage and apoptosis. In contrast, NLRX1 downregulation intensified these adverse effects. Further mechanistic studies indicated that NLRX1's interaction with TRAF6 was crucial for its anti-inflammatory effects, which could be nullified by TRAF6 blockade. Moreover, in vitro assays showed that NLRX1 could drive KCs to transition from a pro-inflammatory M1 to an anti-inflammatory M2 phenotype via the PI3K/Akt pathway. Overall, our results imply that targeting NLRX1 in conjunction with mTOR could be a viable approach to prevent hepatic AR, and suggest potential cross-talk between TRAF6-dependent inflammatory suppression and PI3K/Akt-mediated M2 polarization that requires further validation.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153141"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The expression of OX40 in CD4+ T cells and its association with hepatic fibrosis injury OX40在CD4+ T细胞中的表达及其与肝纤维化损伤的关系
IF 2.3 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 Epub Date: 2025-11-22 DOI: 10.1016/j.imbio.2025.153143
YaLing Xu , WenNa Li , Yuan Li , Xin Li , XinNa Li , Bo Wang

Purpose

OX40 is a typical member of the co-stimulatory molecule family. The signals generated by its binding to OX40L have a synergistic effect, regulating T cell proliferation, differentiation, and influencing cytokine secretion. This study aimed to evaluate the role of OX40 in regulating the progression of liver fibrosis induced by CCL4-induced inflammation.

Patients and methods

OX40 expression levels in tissue samples from individuals with liver fibrosis and healthy controls were analyzed using the Gene Expression Omnibus (GEO) database. Furthermore, a murine model of liver fibrosis was established by administering CCL4 through continuous intraperitoneal injections over an 8-week period. The extent of liver fibrosis was evaluated through histopathological staining. Flow cytometry was employed to identify CD4+ T lymphocytes and to track the dynamic expression of OX40 on these cells in splenic samples throughout the progression of liver fibrosis.

Results

Database analysis revealed that OX40 expression was significantly upregulated in liver fibrosis tissues compared to corresponding normal tissues. Following CCL4 induction, there was a marked increase in alanine transaminase (ALT) and aspartate aminotransferase (AST) levels. Hematoxylin and eosin (HE) staining, along with Masson's trichrome staining, highlighted the presence of damaged tissue architecture in the murine models. Additionally, the upregulation of OX40 expression in liver fibrosis showed a positive correlation with elevated levels of alpha-smooth muscle actin (α-SMA) and the production of collagen fibers. ELISA results indicate that interference with the OX40 molecule can affect cytokine expression. Blocking the OX40-OX40L signaling pathway can, to some extent, regulate the direction of immune polarization.

Conclusion

These results suggest that the OX40 molecule may be involved in the immune imbalance occurring during the development and progression of liver fibrosis, thereby contributing to hepatic tissue injury.
目的:ox40是一个典型的共刺激分子家族成员。其与OX40L结合产生的信号具有协同作用,调节T细胞增殖、分化,影响细胞因子分泌。本研究旨在评估OX40在ccl4诱导的炎症诱导的肝纤维化进展中的调节作用。采用基因表达综合数据库(Gene expression Omnibus, GEO)分析肝纤维化患者和健康对照组组织样本中sox40的表达水平。此外,通过连续8周腹腔注射CCL4建立小鼠肝纤维化模型。通过组织病理学染色评估肝纤维化程度。采用流式细胞术鉴定CD4+ T淋巴细胞,并在肝纤维化的整个过程中跟踪脾脏样本中这些细胞上OX40的动态表达。结果数据库分析显示,与相应的正常组织相比,OX40在肝纤维化组织中的表达明显上调。CCL4诱导后,谷丙转氨酶(ALT)和天冬氨酸转氨酶(AST)水平显著升高。苏木精和伊红(HE)染色,以及马松三色染色,突出了小鼠模型中受损组织结构的存在。此外,OX40在肝纤维化中的表达上调与α-平滑肌肌动蛋白(α-SMA)水平升高和胶原纤维的产生呈正相关。ELISA结果表明,干扰OX40分子可影响细胞因子的表达。阻断OX40-OX40L信号通路可以在一定程度上调节免疫极化的方向。结论OX40分子可能参与肝纤维化发生发展过程中的免疫失衡,从而导致肝组织损伤。
{"title":"The expression of OX40 in CD4+ T cells and its association with hepatic fibrosis injury","authors":"YaLing Xu ,&nbsp;WenNa Li ,&nbsp;Yuan Li ,&nbsp;Xin Li ,&nbsp;XinNa Li ,&nbsp;Bo Wang","doi":"10.1016/j.imbio.2025.153143","DOIUrl":"10.1016/j.imbio.2025.153143","url":null,"abstract":"<div><h3>Purpose</h3><div>OX40 is a typical member of the co-stimulatory molecule family. The signals generated by its binding to OX40L have a synergistic effect, regulating T cell proliferation, differentiation, and influencing cytokine secretion. This study aimed to evaluate the role of OX40 in regulating the progression of liver fibrosis induced by CCL4-induced inflammation.</div></div><div><h3>Patients and methods</h3><div>OX40 expression levels in tissue samples from individuals with liver fibrosis and healthy controls were analyzed using the Gene Expression Omnibus (GEO) database. Furthermore, a murine model of liver fibrosis was established by administering CCL4 through continuous intraperitoneal injections over an 8-week period. The extent of liver fibrosis was evaluated through histopathological staining. Flow cytometry was employed to identify CD4+ T lymphocytes and to track the dynamic expression of OX40 on these cells in splenic samples throughout the progression of liver fibrosis.</div></div><div><h3>Results</h3><div>Database analysis revealed that OX40 expression was significantly upregulated in liver fibrosis tissues compared to corresponding normal tissues. Following CCL4 induction, there was a marked increase in alanine transaminase (ALT) and aspartate aminotransferase (AST) levels. Hematoxylin and eosin (HE) staining, along with Masson's trichrome staining, highlighted the presence of damaged tissue architecture in the murine models. Additionally, the upregulation of OX40 expression in liver fibrosis showed a positive correlation with elevated levels of alpha-smooth muscle actin (α-SMA) and the production of collagen fibers. ELISA results indicate that interference with the OX40 molecule can affect cytokine expression. Blocking the OX40-OX40L signaling pathway can, to some extent, regulate the direction of immune polarization.</div></div><div><h3>Conclusion</h3><div>These results suggest that the OX40 molecule may be involved in the immune imbalance occurring during the development and progression of liver fibrosis, thereby contributing to hepatic tissue injury.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 6","pages":"Article 153143"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145614742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Immunobiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1